HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Doria Selected Research

Nuclear Antigens (Extractable Nuclear Antigens)

1/2022Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
7/2009Commercial blot assays in the diagnosis of systemic rheumatic diseases.
2/2005Anti-Mi-2 antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Doria Research Topics

Disease

56Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 04/2002
26Autoimmune Diseases (Autoimmune Disease)
05/2022 - 03/2005
20Myositis (Idiopathic Inflammatory Myopathies)
10/2022 - 02/2005
20Inflammation (Inflammations)
01/2022 - 03/2005
19Rheumatoid Arthritis
04/2022 - 01/2005
17Lupus Nephritis
08/2022 - 09/2006
12Connective Tissue Diseases (Connective Tissue Disease)
05/2022 - 07/2002
12Proteinuria
01/2022 - 09/2006
11Dermatomyositis (Dermatopolymyositis)
10/2022 - 02/2005
11Psoriatic Arthritis
01/2022 - 03/2005
11Rheumatic Diseases (Rheumatism)
03/2020 - 01/2006
9Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2020 - 07/2005
8Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 08/2007
8Arthritis (Polyarthritis)
01/2022 - 01/2005
7Infections
01/2022 - 09/2007
7Polymyositis
01/2017 - 08/2007
6Neoplasms (Cancer)
10/2022 - 12/2009
6Hypertension (High Blood Pressure)
11/2021 - 06/2011
6Thrombosis (Thrombus)
12/2020 - 07/2005
5COVID-19
01/2022 - 07/2020
5Atherosclerosis
01/2021 - 06/2005
5Necrosis
10/2018 - 01/2005
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2022 - 03/2020
4Vasculitis (Vasculitides)
01/2022 - 03/2005
4Axial Spondyloarthritis
01/2022 - 01/2020
4Fibrosis (Cirrhosis)
01/2020 - 01/2017
4Muscular Diseases (Myopathy)
10/2016 - 12/2014
3Immunoglobulin G4-Related Disease
05/2022 - 03/2014
3Ankylosing Spondylitis
01/2022 - 03/2005
3Osteoarthritis
01/2022 - 09/2015
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 03/2005
3Adult-Onset Still's Disease
01/2022 - 01/2020
3Churg-Strauss Syndrome (Allergic Angiitis)
11/2021 - 09/2007
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020 - 11/2019
3Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 12/2012
3Pain (Aches)
07/2013 - 02/2008
3Crohn Disease (Crohn's Disease)
09/2007 - 03/2005
2Inclusion Body Myositis
10/2022 - 01/2017
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
03/2022 - 09/2007
2Pregnancy Complications
01/2022 - 01/2018
2Gout
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

39AutoantibodiesIBA
10/2022 - 02/2005
36AntibodiesIBA
10/2022 - 07/2002
14Biological ProductsIBA
01/2022 - 01/2005
13CytokinesIBA
05/2022 - 12/2004
12Biomarkers (Surrogate Marker)IBA
05/2022 - 08/2007
11Immunoglobulin G (IgG)IBA
11/2021 - 07/2005
10Proteins (Proteins, Gene)FDA Link
10/2022 - 08/2002
10Pharmaceutical PreparationsIBA
04/2022 - 11/2005
10belimumabIBA
01/2022 - 11/2012
9Immunosuppressive Agents (Immunosuppressants)IBA
07/2021 - 07/2013
9AutoantigensIBA
01/2015 - 06/2005
8Rituximab (Mabthera)FDA Link
07/2021 - 09/2007
7Ligases (Synthetase)IBA
10/2022 - 10/2011
7Prednisone (Sone)FDA LinkGeneric
01/2022 - 07/2013
7CreatinineIBA
01/2022 - 09/2006
7Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2022 - 07/2005
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2005
7Antiphospholipid AntibodiesIBA
12/2020 - 06/2005
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 09/2006
6GlucocorticoidsIBA
07/2021 - 11/2012
5Antirheumatic Agents (DMARD)IBA
01/2022 - 10/2018
5Interleukin-1 (Interleukin 1)IBA
01/2022 - 11/2015
5SteroidsIBA
01/2022 - 04/2002
5Antinuclear AntibodiesIBA
01/2022 - 06/2005
5Immunoglobulin M (IgM)IBA
01/2021 - 01/2013
5Monoclonal AntibodiesIBA
01/2014 - 03/2005
5AntigensIBA
04/2013 - 02/2005
4RNA (Ribonucleic Acid)IBA
10/2022 - 10/2012
4Methotrexate (Mexate)FDA LinkGeneric
04/2022 - 10/2010
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2022 - 03/2020
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2015
4EnzymesIBA
11/2021 - 11/2006
4beta-cyclodextrin tetradecasulfate (CTDS)IBA
11/2021 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2007
4Phospholipids (Phosphatides)FDA LinkGeneric
12/2020 - 11/2006
4Rheumatoid FactorIBA
01/2018 - 06/2005
4Infliximab (Remicade)FDA Link
10/2017 - 03/2005
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 01/2021
3Antimalarials (Antimalarial Agents)IBA
01/2022 - 03/2017
3Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2022 - 02/2005
3secukinumabIBA
01/2022 - 01/2021
3amsonic acid (DAS)IBA
12/2021 - 01/2019
3InterleukinsIBA
04/2021 - 11/2015
3C-Reactive ProteinIBA
01/2021 - 06/2007
3Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 09/2006
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2021 - 01/2007
3Antigen-Antibody Complex (Immune Complex)IBA
01/2020 - 06/2012
3Transfer RNA (tRNA)IBA
11/2019 - 10/2011
3Peptides (Polypeptides)IBA
01/2017 - 06/2005
3ChromatinIBA
05/2016 - 06/2005
3anti-dsDNA autoantibodyIBA
12/2014 - 06/2005
3Adalimumab (Humira)FDA Link
10/2014 - 01/2005
2ChemokinesIBA
05/2022 - 05/2017
2tocilizumab (atlizumab)FDA Link
01/2022 - 07/2013
2VaccinesIBA
01/2022 - 02/2005
2baricitinibIBA
01/2022 - 09/2019

Therapy/Procedure

25Therapeutics
08/2022 - 09/2006
3Biological Therapy
01/2022 - 02/2014
3Off-Label Use
01/2016 - 03/2005